NOTE 11 - STOCKHOLDERS' DEFICIENCY: Stock Issuances (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2020
USD ($)
$ / shares
shares
| |
| Transaction 6 | |
| Sale of Stock, Description of Transaction | Company issued 3,744,588 shares of its common stock |
| Issuance of common stock for cash, Shares | shares | 3,744,588 |
| Sale of Stock, Price Per Share | $ / shares | $ 0.11 |
| Stock Issued | $ | $ 400,866 |
| Transaction 7 | |
| Sale of Stock, Description of Transaction | the Company issued 26,500,000 shares of its common stock |
| Issuance of common stock for cash, Shares | shares | 26,500,000 |
| Sale of Stock, Price Per Share | $ / shares | $ 0.10 |
| Stock Issued | $ | $ 2,650,000 |
| X | ||||||||||
- Definition Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition The fair value of stock issued in noncash financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|